Inactive Instrument

Cephalon, Inc. Share Price

Equities

End-of-day quote Nasdaq Other stock markets
- ^USD	-

2015	AstraZeneca : Teva reach deal with states in Medicaid pricing case	RE
2014	Actavis : Exclusive - Valeant to drop deal-making in near term to cut debt, boost stock	RE

AstraZeneca : Teva reach deal with states in Medicaid pricing case	04/11/15	RE
Actavis : Exclusive - Valeant to drop deal-making in near term to cut debt, boost stock	09/12/14	RE

CEPHALON : Teva Completes Acquisition of Cephalon	14/10/11	BU
CEPHALON : Announces Enrollment In the Risk Evaluation and Mitigation Strategy Program for FENTORA and ACTIQ	13/10/11	PU
CEPHALON : Teva and Cephalon Receive European Commission Approval For Acquisition	13/10/11	BU
CEPHALON : Gives Notice of Anticipated Fundamental Change to Holders of Its 2.50% Convertible Senior Subordinated Notes due 2014 and 2.00% Convertible Senior Subordinated Notes due 2015	22/08/11	PR
CEPHALON : Reported Financial Results for the Second Quarter of 2011	02/08/11	PR

CEPHALON : bond des bénéfices au premier trimestre	04/05/11
CEPHALON : Valeant Pharmaceuticals lance une OPA de 5,7 MdUSD sur CEPHALON	30/03/11

Sector

	1st Jan change	Capi.
UPM-KYMMENE OYJ	-2.70%	19.03B
SUZANO S.A.	-10.66%	11.72B
SVENSKA CELLULOSA AKTIEBOLAGET SCA	+3.51%	10.31B
HOLMEN AB	-0.07%	6.4B
EMPRESAS CMPC S.A.	+4.59%	4.73B
OJI HOLDINGS CORPORATION	+16.26%	3.85B
CENTURY TEXTILES AND INDUSTRIES LIMITED	+86.66%	3.06B
THE NAVIGATOR COMPANY, S.A.	+8.29%	2.94B
SAPPI LIMITED	+8.80%	1.57B